| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |